Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2014 1
2015 1
2017 1
2018 1
2020 1
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD.
Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH, Karakan T, Katsanos KH, Krustins E, Levine A, Mantzaris GJ, O'Morain C, Strid H, Yuksel ES, Annese V. Maaser C, et al. Among authors: ramirez vh. J Crohns Colitis. 2017 Aug 1;11(8):905-920. doi: 10.1093/ecco-jcc/jjw223. J Crohns Colitis. 2017. PMID: 28039310 Review.
The right colon challenge.
Cid Gómez LA, Fernández Fernández N, Hernández Ramírez V. Cid Gómez LA, et al. Among authors: hernandez ramirez v. Rev Esp Enferm Dig. 2018 Mar;110(3):135-137. doi: 10.17235/reed.2018.5544/2018. Rev Esp Enferm Dig. 2018. PMID: 29465249 Free article.
Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.
Hernández V, de Castro ML, Salinas-Rojo M, Fernández A, Martínez-Ares D, Sanromán L, Pineda JR, Carmona A, Salgado-Álvarez C, Martínez-Cadilla J, Pereira S, García-Burriel JI, González-Portela C, Vázquez S, Rodríguez-Prada JI; Epi-IBD. Hernández V, et al. Rev Esp Enferm Dig. 2022 Feb;114(2):103-106. doi: 10.17235/reed.2021.8003/2021. Rev Esp Enferm Dig. 2022. PMID: 34154368 Free article.
Post-marketing health technology monitoring. The analysis of an experience from a clinical perspective.
Ibargoyen-Roteta N, Cabriada-Nuño JL, Gutiérrez-Ibarluzea I, Hernández-Ramírez V, Clofent-Vilaplana J, Domènech-Morral E, Ginard-Vicens D, Oliva-Oliva G, Queiro-Verdes T. Ibargoyen-Roteta N, et al. Among authors: hernandez ramirez v. Front Pharmacol. 2011 Jul 29;2:45. doi: 10.3389/fphar.2011.00045. eCollection 2011. Front Pharmacol. 2011. PMID: 21863141 Free PMC article.
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study.
Katsanos KH, Tatsioni A, Pedersen N, Shuhaibar M, Ramirez VH, Politi P, Rombrechts E, Pierik M, Clofent J, Beltrami M, Bodini P, Freitas J, Mouzas I, Fornaciari G, Moum B, Lakatos PL, Vermeire S, Langholz E, Odes S, Morain CO, Stockbrügger R, Munkholm P, Tsianos EV. Katsanos KH, et al. Among authors: ramirez vh. J Crohns Colitis. 2011 Oct;5(5):430-42. doi: 10.1016/j.crohns.2011.04.013. Epub 2011 May 18. J Crohns Colitis. 2011. PMID: 21939917
12 results